Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.
The emergence of clinical enterococcal isolates resistant to both ampicillin and vancomycin is a cause of great concern, as there are few therapeutic alternatives for treatment of infections caused by such organisms. We evaluated the effects of the combination of ampicillin with vancomycin against v...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1992
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245476/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1444300/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.10.2201 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|